By Editor , 30 October 2026

60,000 White Flags to Fill the National Mall for Lung Cancer

Lead Image
60,000 White Flags to Fill the National Mall for Lung Cancer

WASHINGTON – October 29, 2026 -- LUNGevity Foundation's Every Breath Forward campaign will plant 60,000 white flags on the National Mall on November 1. During Lung Cancer Awareness Month, anyone can join through a home display, a volunteer shift, or a virtual dedication.

Each flag honors two lives lost to lung cancer

Each flag represents two of the more than 120,000 people who die from lung cancer in the United States every year. Volunteers will plant the flags, and a Survivor Rally will honor survivors and call for greater awareness and research.

By Editor , 17 October 2026

AbbVie Presents 20 IBD Abstracts at UEGW 2026 in Barcelona

North Chicago – October 17, 2026 -- AbbVie (NYSE: ABBV) is presenting 20 new scientific abstracts from its inflammatory bowel disease (IBD) portfolio at the 2026 United European Gastroenterology (UEG) Week, held October 17-20 in Barcelona, Spain. The data cover long-term and real-world outcomes for Skyrizi (risankizumab) and Rinvoq (upadacitinib) in Crohn's disease (CD) and ulcerative colitis (UC).

By Editor , 15 October 2026

Brainomix Teams With PFF to Test AI Lung CT Analysis With Patients

Brainomix Teams With PFF to Test AI Lung CT Analysis With Patients

Oxford – October 14, 2026 -- Brainomix has partnered with the Pulmonary Fibrosis Foundation (PFF) to test how patients and caregivers respond when its FDA-cleared, CE-marked e-Lung quantitative CT analysis is built into clinicians' assessment workflow for pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

By Editor , 7 October 2026

FDA Clears Quarterable PREVICOX Tablet for Precision Canine Dosing

FDA Clears Quarterable PREVICOX Tablet for Precision Canine Dosing

Johns Creek, Ga. – October 07, 2026 -- Boehringer Ingelheim has secured U.S. Food and Drug Administration approval for a new Quarterable Snap-Tab design of PREVICOX (firocoxib) Chewable Tablets, enabling veterinarians to prescribe the canine pain medication to dogs as small as seven pounds.

By Editor , 19 September 2026

New Campaign Targets Early Warning Signs of Progressive Lung Scarring

Lead Image
New Campaign Targets Early Warning Signs of Progressive Lung Scarring

Chicago – September 18, 2026 -- The American Lung Association has launched a national campaign to help patients and caregivers recognize the early warning signs of progressive pulmonary fibrosis (PPF), timed to World Interstitial Lung Disease Day.

Boehringer Ingelheim